chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sick; Initial information received on 05-Feb-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who reported sick while receiving vaccine INFLUENZA USP TRIVAL A-B VACCINE-UNSPECIFIED [FLUZONE UNSP].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED lot number not reported via unknown route in unknown administration site for immunization.  On an unknown date the patient developed a non-serious event "sick" (illness) (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED.  It was reported "Every time I get a flu shot I get sick with the flu. I ask my doctor why. He said there's over 200 variants and I happen to get the wrong one. Now I been healthy and well since I haven't gotten the shot. It's like playing roulette with over 200 chances".  INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED was discontinued on an unknown date.  It was not reported if the patient received a corrective treatment for the event (sick).  At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event sick.
Five days later my body was itching uncontrollably. 6 months later its better but i still have itching issues and take meds for it
Repeatative seizures started approx 12 hours after vaccines. Multiple seizures during the next several hours, baby then given Phenobarbital to stop seizures.  12/1/06 Received medical records which reveal:  On 10/21/06 seen in ER for fever & seizure/s/p vax (presumed DTaP).  LP done.  Received IVF.  Developed diarrhea.
p/vax pt fatigued to where can never get enough sleep, high blood pressure & migraine h/a that med will not alleviate;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 20-MAR-2013, the patient was inoculated with ZOSTAVAX at a physician's office as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 01-DEC-2016, the patient was treated at the same physician's office for the onset of vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcomes of the events were unknown at the time of reporting. Causality assessment was related. Additional information has been requested.
The Patient received the PREVNAR vaccine on 10/31/2018 and came into the store on 02/08/2019 complaining of a local injection site pain that has been sustained since the day of administration. Patient was advised to follow up with his primary care physician while taking over-the counter Motrin for mild pain relief sparingly as needed.
Trumenba was admin to the pt L deltoid w/ no voiced complaints @ approx 2:20pm. Pt remained alert. About 1-2 min later the #2 Menaetra vaccine was admin to the pt R deltoid w/ no voiced compliments. Moments later, about 1-2 min following the injection the RN noticed the pt's eyes close & her head began leaning forward. Pt become unresponsive to voice or touch to the shoulder. The pt's eyes closed & her head & eyes rolled backward. Pt began to have severe like activity w/ extraocular eye movements w/ upper lower extremity muscle retraction which lasted about 15 seconds. RN immediately inspected The pt & her surrounds to minimize risk of injury. Pt regained conciousness. Pt was notably disonented & hypotensive w/ a manual pressure of 70/30 HR 52 + Sp02 99% on mm air. Ems called. No head or tongue injuries sustained. No loss of bowel or bladder functions. Dr alerted & came to eval the pt. Pt given Po fluids and instructed to remain seated until EMS arrived. Pt transported in stable condition.
Pt given vaccines 12/27 in PM. Cried inconsolably most of night. Became extremely lethargic morning of 12/28. Refused feeding, began coughing and losing his voice. Was difficult to arouse. Hospitalized.
High fever; Dizziness; Nausea; Fatigue to the point of falling asleep while sitting up; Fatigue to the point of falling asleep while sitting up; Swelling and pain in left armpit/ axial region so much so that my bras don't fit properly; Pain in left armpit/ axial region so much so that my bras don't fit properly; Dose received 3; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in left arm, administration date 29Nov2021 at 15:30 (Lot number: unknown) at the age of 39 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Penicillin allergy" (unspecified if ongoing), notes: Known allergies: PCN. Concomitant medications included: METFORMIN, HYDROXYZINE and BIRTH CONTROL. Vaccination history included: BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, DOSE 2, SINGLE, Lot number: UNKNOWN, Anatomical site: Left arm, Administration time: 12:00, Route of administration: unspecified), administration date: 26Apr2021, and BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, DOSE 1, SINGLE, Lot number: UNKNOWN, Anatomical site: Left arm, Administration time: 12:00, Route of administration: unspecified), administration date: 06Apr2021, both when the patient was 38 years old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 29Nov2021 at 15:30, outcome "unknown", described as "Dose received 3"; PYREXIA (non-serious) with onset 30Nov2021 at 06:00, outcome "not recovered", described as "High fever"; DIZZINESS (non-serious) with onset 30Nov2021 at 06:00, outcome "not recovered", described as "Dizziness"; NAUSEA (non-serious) with onset 30Nov2021 at 06:00, outcome "not recovered", described as "Nausea"; FATIGUE (non-serious), SOMNOLENCE (non-serious), SWELLING (non-serious), AXILLARY PAIN (non-serious) all with onset 30Nov2021 at 06:00, outcome "not recovered", and all described as "Fatigue to the point of falling asleep while sitting up". The events "High fever", "Dizziness", "Nausea", "Fatigue to the point of falling asleep while sitting up", "Swelling and pain in left armpit/ axial region so much so that my bras don't fit properly" and "Pain in left armpit/ axial region so much so that my bras don't fit properly" were evaluated at the physician office visit. It was unknown whether therapeutic measures were taken as a result of pyrexia, dizziness, nausea, fatigue, somnolence, swelling and axillary pain.  Additional Information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for BNT162b2 was not provided and will be requested during follow up.
patient had high fever a few hours later (about 4 hours after shot) and it lasted for 24 hours+, severe headache, body aches (muscle and joints), SOB and wheezing on 8/14 for which she used rescue inhaler, bumps on right shoulder, itchy arms, woke up 8/15 lips double size, tongue ulcerated and swollen - today 8/15 is dizzy, has been taking Benadryl and prescribed oral steroid therapy
Left deltoid swollen and red around injection site (1-2 inches), not hot to touch, no itching; Painful to student. Prednisone 60 mg.
I vomited once and had diarrhea the night after getting my second dose of the vaccine.; I vomited once and had diarrhea the night after getting my second dose of the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8733) via an unspecified route of administration in the arm left on 26Mar2021 at 11:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, anxiety, chronic eye issues and penicillin allergy. Concomitant medications included escitalopram oxalate (LEXAPRO) and doxepin (MANUFACTURER UNKNOWN); for unknown indication from an unspecified date. The patient previously received vicodin (MANUFACTURER UNKNOWN) for unknown indication on an unspecified date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the arm left on 05Mar2021 at 10:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 01:00, the patient vomited once and had diarrhea the night after getting the second dose of the vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events vomiting was recovered on 27Mar2021; while that of the event diarrhea was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
When I woke up this morning (9/15/21), I noticed a large red rash around the injection site-above and below the injection site .  I looked online and found that this is what?s called ?Covid Arm.?  I went to the pharmacy, and the pharmacist said it will last 7-10 days.
Patient stepped on glass and received TD on 4/30/10. The next day (5/1/10) the injection site was hard and swollen. On 5/3/10, she was zoned out, tired, depressed, wanted to cry, obsessive with thoughts, and couldn't "get connections with her thought form", and couldn't function. On 5/4/10, patient's arms felt "like they had lead on them", her arm twitched, but that symptom has since resolved. She was very fatigued, had a horrible headache, lots of gas, and her stomach was swollen. The gas and swollen stomach symptoms have resolved as of 5/5/10. On 5/4/10, patient called clinic and was told to go to bed, drink lots of fluids, and go to the ER. Patient did not go to ER. On the evening of 5/4/10, the patient called the provider of the vaccine and again was told to go to the ER, and again, she did not. She also called her internist, and they advised her to go to the ER, and suggested she try activated charcoal powder. Patient did not go to ER, but did take some activated charcoal powder on 5/4/10. On 5/5/10, the injection site was warm, with a shooting pain when she touches the injection site. The patient has malaise, her eyes felt like there was too much pressure behind them, although they are feeling better, she feels tightness in her chest, her kidneys hurt, she feels unstable, has muscle spasms in her legs that are not severe, and are from the knee up. Despite this, she claims to be feeling better. Follow up Received 5/26/2010: The patient was contacted to see if her symptoms had resolved. The patient stated that she still has a lot of symptoms, including twitching in her arm, her fingernails went dark around the cuticle; first black, then blue. They are still blue, and the veins in her ankles are dark. The veins in her arms hurt, the nerves hurt, and her arms are very sore. She is having night sweats (she did not have them before receiving TD). Her sleeping patterns have changed, so she is really tired. She has not seen a health care provider for her symptoms, nor has she taken any medications to treat them. Follow up Received 7/7/2010: The patient stated that she was slowly getting better, but she still has some residual issues. She still has some muscle spasms at the site of injection, her kidneys are still hurting, but not every day. She has some back and joint pain, and swelling in her legs and ankles. She had a problem with her stools and a blockage, which has resolved. She is also complaining of very bad problems with her short term memory, which she attributes to the vaccine. The patient is treating her symptoms by taking one level teaspoon of charcoal powder for 5-7 days, waiting for 3-4 days, and then taking it again for 5-7 days.
patient had received Janssen vaccine on 4/9/21.   Made another appointment on 6/22/21 and 7/13/21 and received 2 doses of pfizer vaccine.
Significant pain at injection site and entire left arm, overall body pain, numbness in extremities  and fever up too 101.4. Took ibuprofen to reduce fever. All symptoms but numbness still persist as of 11:22a 6/14/2018. Fever is now 99.8.
Patient is currently in hospital. Patient was unaware he had COVID and thought he was experiencing symptoms from his lung cancer.  Patient is not sure how he may have been exposed to COVID. Patient is fully vaccinated.
A few minutes after the shot I starting feeling faint and heart racing. Mouth was dry and felt nervous.
Pt recvd 3 doses of Engerix-B & was found to be not immune p/completing the series;
Pt looked pale. She moved to chair next to chair that she was sitting in for vaccine. She was talking to RN and then slumped in chair. RN supported her weight while she was out. Pt then had a quick seizure and came to. She was confused and upset. The event happened less than 5 minutes after vaccines were given. She sat on her mom's lap and was tearful and breathing fast. RN ENC her to take slow deep breaths. Pt then walked to room next door and laid on exam table with legs elevated. RN put cool cloth on her head. RN gave her apple juice to sip on and fruit snacks. RN observed pt for about a half hr before pt left. Child reported that before she fainted she had blurry vision and felt really tired. Mom stated that child has never had a seizure before. RN ENC mom to take child to walk in or to her PCP today to be evaluated. Mom stopped at PCP's office and nurse there stated that if she had symptoms again to bring her in to be seen. She was not seen by nurse or PCP. RN called mom to CK in this afternoon. She reports that child threw up on the way home and reported feeling much better afterward.
Pt called 7/23/14 to report swollen, warm to touch arm at injection site. Pt came in to pharmacy 7/24/14. After reviewing/analyzing pt's arm, injection site is red/swollen and warm to touch. Diameter is size of half dollar. Instructed pt on 7/23/14 to take BENADRYL to see if it would help. Pt states that it did not help. Advised pt to see physician d/t possible infection.
Anerexia, dizziness, chest pain. Called ER on 12/02/2002. Evaluated on 12/10/2002 with complaints of having had nausea, tiredness, fatigue, sore throat, dizziness, left side pain.
- Nausea (without the ability to vomit) (began 8pm lasted until 1am the following day) - Skin sensitivity (i.e. hurts to be touched) (began 8pm, on going) - Headache (began 8pm, ongoing) - High heart rate (began 8pm lasted until 1am the following day) - Fever (began 8pm, on going) - Anxiety/irritability without an inciting event (began 8pm lasted until 1am the following day)
From 4/7 Swollen gland near armpit, first right, then left a couple days later  From 4/7 Rash under right breast, then left breast next day. Suspected to be fungal rash by doctor.   From 4/6 Renewed moderate pain and warmth at injection site that had largely subsided. Injection site pain flares on some days to date   From 4/6 Renewed and continuing fever and fatigue, headaches, malaise to date. Temp consistently 99.5 to date.
Initial unsolicited report received from a other-healthcare professional via other company (Pfizer) (manufacturer report number: 2016342664) on 21-JUL-2016. This case involves a 16-year-old female patient who was vaccinated with a dose of MENACTRA and a 0.5 ml dose of TRUMENBA, (for both the vaccines batch number, expiry date, dose in series, route and site of administration were not reported) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient passed out for a few seconds. Lab data and corrective treatment was not reported. On an unspecified date, the patient was recovered from event. Upon medical review, the case was considered as serious due to important medical event: passed out for a few seconds. List of documents held by sender: none. Sender's Comments: This a poorly documented case as patient passed out for few seconds following MENACTRA and TRUMENBA VACCINE. Detail medical history, past vaccination history and its tolerance are needed to further assess this case. As multiple vaccine are administered, the role each vaccine cannot be evaluated.
Forgetful occasionally; chemical or abrasion irritation of skin; Obesity; Swollen mouth; Feet burning; Body itching; Rash; Chills; fever/high temperature; This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (Forgetful occasionally), SKIN IRRITATION (chemical or abrasion irritation of skin), OBESITY (Obesity), MOUTH SWELLING (Swollen mouth) and BURNING SENSATION (Feet burning) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    The patient's past medical history included Tick bite. Concurrent medical conditions included Crohn's disease and Diabetes.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In July 2021, the patient experienced PYREXIA (fever/high temperature). On an unknown date, the patient experienced MEMORY IMPAIRMENT (Forgetful occasionally), SKIN IRRITATION (chemical or abrasion irritation of skin), OBESITY (Obesity), MOUTH SWELLING (Swollen mouth), BURNING SENSATION (Feet burning), PRURITUS (Body itching), RASH (Rash) and CHILLS (Chills). At the time of the report, MEMORY IMPAIRMENT (Forgetful occasionally), RASH (Rash), PYREXIA (fever/high temperature) and CHILLS (Chills) outcome was unknown and SKIN IRRITATION (chemical or abrasion irritation of skin), OBESITY (Obesity), MOUTH SWELLING (Swollen mouth), BURNING SENSATION (Feet burning) and PRURITUS (Body itching) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Typhus rickettsia test: (Positive) Positive.         No concomitant medications were reported.   It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's causality for the event(s) of tick bite, forgetful occasionally, diabetes, obesity, chills, swollen mouth, feet burning, body itching, fever/high temperature, rash and positive for spotted tick fever was not provided. The reporter's causality for the event(s) of chemical or abrasion irritation of skin with Humira (adalimumab) was no reasonable possibility. Reporter assessed events of tick bite, forgetful occasionally, diabetes, obesity, chills, swollen mouth, feet burning, body itching, fever/high temperature, rash and positive for spotted tick fever and chemical or abrasion irritation of skin as possibly related to Moderna Covid-19 vaccine.  No treatment details were reported.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Headache, Myalgia, Arthralgia, Malaise, chills Narrative:  Other Relevant History:
had a fever of 103F; joint pain; achiness; This is a spontaneous report from a Pfizer-sponsored program, also from a non-contactable consumer (parent). A 23-year-old male patient (reporter's son) received bnt162b2 (COVID 19 Vaccine, mRNA), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation  .  Medical history and concomitant medications were not reported. The patient was tested positive for COVID and then received his first dose of the Pfizer COVID vaccine 4 weeks later. He had major side effects from the vaccine. He had a fever of 103F, joint pain and achiness that lasted for 2-3 days. He's in the military and was forced to get the vaccine. The reporter asked after getting the virus, is there a time frame that a person should wait before getting the vaccine? Is the emergency use vaccine the same ingredients as the one approved by the FDA? The patient underwent lab tests and procedures which included pyrexia: 103 fahrenheit, tested positive for COVID on an unknown date. The outcome of achiness was recovered. The outcome of other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Total of three separate occupancies of body aches/joint pain along with numbing sensation from legs to feet. First time being within 24 hours of vaccination, second time occurring around JAN 30, and third occurrence happening today FEB 06. 1000mg acetaminophen was taken once symptoms onset, that provided relief until symptoms eventually subset.
No adverse symptoms reported; was vaccinated with both an adult and pediatric dose of VAQTA; Information has been received from a medical assistant referring to a 60 year old patient of unknown gender. The patient's medical history, concurrent condition and concomitant medication were not provided.  On 16-JUL-2019, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (an adult dose and a pediatric dose; strength, frequency, route, batch/lot number and expiration date were not provided) for prophylaxis. The patient was supposed to receive an adult dose of hepatitis a vaccine, inactivated (VAQTA) instead of the pediatric dose of hepatitis a vaccine, inactivated (VAQTA) (Inappropriate dose of vaccine administered). No adverse symptoms were reported.
Prior to administration of the vaccine, I discussed with mom and patient about previous  immunizations and the YES response to previously fainting or felt dizzy post immunization.  Mom proceeded to state that he has a strong vaso-vagal response to needles/immunizations and he has fainted multiple times during and after immunizations.  The patient appeared calm, so I did some breathing exercises with him and when I determined that he was calm, I administered the vaccine.  Patient was still sitting upright, I asked him to continue to breathe slowly and deeply. I asked if he would like a water, and so I went to grab it from the pharmacy lab.  Patient then stated he was dizzy and was going to pass out.  He did not pass out, and I asked him if he would like to lay down. I put down a towel for him and then he started to throw up. I got a cold washcloth for his neck.  He started sweating profusely (essentially a marked cholinergic response).  I got him to lay down after some more vomiting . He stated that his vision was blurry, but he was laying down calmly.  after 25 minutes of reclining, he stated he was starting to feel a bit better. I offered a 25mg diphenhydramine tablet to help with residual nausea. He stated he was better and go shop with his family.  They did not return to the pharmacy, so as of my last interaction, he was fully recovered from the event.